Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells.

Carraway RE, Hassan S, Dobner PR.

Regul Pept. 2008 Apr 10;147(1-3):96-109. doi: 10.1016/j.regpep.2008.01.009. Epub 2008 Feb 11.

PMID:
18313772
2.

Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells.

Carraway RE, Gui X, Cochrane DE.

J Pharmacol Exp Ther. 2003 Nov;307(2):640-50. Erratum in: J Pharmacol Exp Ther. 2004 Apr;309(1):439.

3.

Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells.

Carraway RE, Hassan S, Cochrane DE.

Prostaglandins Leukot Essent Fatty Acids. 2006 Feb;74(2):93-107. Epub 2006 Jan 6.

PMID:
16406549
4.
5.
6.

Possible role of duration of PKC-induced ERK activation in the effects of agonists and phorbol esters on DNA synthesis in Panc-1 cells.

Rácz GZ, Szucs A, Szlávik V, Vág J, Burghardt B, Elliott AC, Varga G.

J Cell Biochem. 2006 Aug 15;98(6):1667-80.

PMID:
16637058
7.

Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations.

Seethalakshmi L, Mitra SP, Dobner PR, Menon M, Carraway RE.

Prostate. 1997 May 15;31(3):183-92.

PMID:
9167771
8.
9.

Protein kinase C is inhibited by bisphosphonates in prostate cancer PC-3 cells.

Tatsuda Y, Iguchi K, Usui S, Suzui M, Hirano K.

Eur J Pharmacol. 2010 Feb 10;627(1-3):348-53. doi: 10.1016/j.ejphar.2009.10.067. Epub 2009 Nov 10.

PMID:
19903468
10.

Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway.

Yin L, Bennani-Baiti N, Powell CT.

J Biol Chem. 2005 Feb 18;280(7):5533-41. Epub 2004 Dec 16.

11.

Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells.

Gonzalez-Guerrico AM, Meshki J, Xiao L, Benavides F, Conti CJ, Kazanietz MG.

J Biochem Mol Biol. 2005 Nov 30;38(6):639-45. Review.

PMID:
16336777
12.

Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.

van der Merwe JQ, Moreau F, MacNaughton WK.

Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1258-66. doi: 10.1152/ajpgi.90425.2008. Epub 2009 Apr 9.

13.

The regulation of glycine transporter GLYT1 is mainly mediated by protein kinase Calpha in C6 glioma cells.

Morioka N, Abdin JM, Morita K, Kitayama T, Nakata Y, Dohi T.

Neurochem Int. 2008 Dec;53(6-8):248-54. doi: 10.1016/j.neuint.2008.08.002. Epub 2008 Aug 19.

PMID:
18778746
14.

Phorbol ester-mediated neurotensin secretion is dependent on the PKC-alpha and -delta isoforms.

Li J, Hellmich MR, Greeley GH Jr, Townsend CM Jr, Evers BM.

Am J Physiol Gastrointest Liver Physiol. 2002 Nov;283(5):G1197-206.

16.

Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function.

Mundell SJ, Jones ML, Hardy AR, Barton JF, Beaucourt SM, Conley PB, Poole AW.

Mol Pharmacol. 2006 Sep;70(3):1132-42. Epub 2006 Jun 27.

17.
18.

Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.

Sosnowski J, Stetter-Neel C, Cole D, Durham JP, Mawhinney MG.

J Urol. 1997 Jul;158(1):269-74.

PMID:
9186373
19.

Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes.

Luiken JJ, Ouwens DM, Habets DD, van der Zon GC, Coumans WA, Schwenk RW, Bonen A, Glatz JF.

J Endocrinol. 2009 May;201(2):199-209. doi: 10.1677/JOE-09-0046. Epub 2009 Mar 9.

Supplemental Content

Support Center